Commission Implementing Regulation (EU) 2025/1800of 10 September 2025amending Implementing Regulation (EU) 2023/753 as regards administrative changes to the Union authorisation for the biocidal product family C(M)IT/MIT formulations(Text with EEA relevance)

Commission Implementing Regulation (EU) 2025/1800 of 10 September 2025 amending Implementing Regulation (EU) 2023/753 as regards administrative changes to the Union authorisation for the biocidal product family C(M)IT/MIT formulations (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj. , and in particular Article 50(2) thereof, Whereas: (1) On 12 April 2023, Commission Implementing Regulation (EU) 2023/753 Commission Implementing Regulation (EU) 2023/753 of 12 April 2023 granting a Union authorisation for the biocidal product family C(M)IT/MIT formulations (OJ L 100, 13.4.2023, p. 48, ELI: http://data.europa.eu/eli/reg_impl/2023/753/oj). granted a Union authorisation, under number EU-0025678-0000, to Solenis Switzerland GmbH for the making available on the market and use of the biocidal product family C(M)IT/MIT formulations. The Annex to that Implementing Regulation provides the summary of product characteristics for that biocidal product family. (2) On 1 October 2024, Solenis Switzerland GmbH submitted to the European Chemicals Agency (the Agency), in accordance with Article 11(1) of Commission Implementing Regulation (EU) No 354/2013 Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj). , a notification of administrative change to the Union authorisation for the biocidal product family C(M)IT/MIT formulations, recorded in the register for biocidal products under case number BC-TG100256-47. The notified proposed change concerns the addition of formulators of the biocidal product. (3) On 6 November 2024 ECHA opinion UAD-C-1777770-16-00/F of 6 November 2024 on administrative changes of the Union authorisation of the biocidal product family C(M)IT/MIT formulations, https://echa.europa.eu/opinions-on-union-authorisation. , the Agency submitted to the Commission, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013, an opinion on the notified administrative change to the Union authorisation for the biocidal product family C(M)IT/MIT formulations. In the opinion, the Agency concludes that the proposed change is an administrative change as referred to in Article 50(3), point (a), of Regulation (EU) No 528/2012 and as specified in Title 1, Section 2, of the Annex to Implementing Regulation (EU) No 354/2013, and that after the implementation of the change, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met. (4) On 6 November 2024, the Agency transmitted to the Commission the revised summary of the biocidal product characteristics of the Union authorisation for the biocidal product family C(M)IT/MIT formulations in all official languages of the Union, covering the administrative change applied for, in accordance with Article 11(6) of Implementing Regulation (EU) No 354/2013.

(5) The Commission concurs with the opinion of the Agency and therefore considers it appropriate to amend the Union authorisation for the biocidal product family C(M)IT/MIT formulations to introduce the administrative change requested by Solenis Switzerland GmbH. (6) Except for the amendments regarding the administrative change, all other information included in the summary of the biocidal product characteristics of C(M)IT/MIT formulations as set out in Annex to Implementing Regulation (EU) 2023/753 remain unchanged. (7) In order to enhance clarity and to ease the access of users and interested parties to the consolidated version of the summary of the biocidal product characteristics which is to be published by the Agency, the Annex to Implementing Regulation (EU) 2023/753 should be replaced in its entirety. Due to a change in the format used for the generation of the summary of biocidal product characteristics in the register for biocidal products in February 2024, the summary of biocidal product characteristics in that Annex should also include some minor editorial and layout changes. (8) Implementing Regulation (EU) 2023/753 should therefore be amended accordingly, HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) 2023/753 is replaced by the text set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 10 September 2025. For the Commission The President Ursula von der Leyen

Annex

ANNEX SUMMARY OF PRODUCT CHARACTERISTICS FOR A BIOCIDAL PRODUCT FAMILY C(M)IT/MIT formulations Product type(s) PT06: Preservatives for products during storage PT11: Preservatives for liquid-cooling and processing systems PT12: Slimicides Authorisation number: EU-0025678-0000 R4BP asset number: EU-0025678-0000 PART I. FIRST INFORMATION LEVEL

1. ADMINISTRATIVE INFORMATION 1.1. Family name NameC(M)IT/MIT formulations 1.2. Product type(s) Product type(s) PT06: Preservatives for products during storage PT11: Preservatives for liquid-cooling and processing systems PT12: Slimicides 1.3. Authorisation holder Name and address of the authorisation holderNameSolenis Switzerland GmbHAddressMühlentalstrasse 38 8200 Schaffhausen CHAuthorisation numberEU-0025678-0000R4BP asset numberEU-0025678-0000Date of the authorisation3 May 2023Expiry date of the authorisation31 August 2032 1.4. Manufacturer(s) of the product Name of manufacturerSolenis Switzerland GmbHAddress of manufacturerMühlentalstrasse 38 8200 Schaffhausen SwitzerlandLocation of manufacturing sites Solenis Switzerland GmbH site 1 Fütingsweg 20 D-47805 Krefeld Germany Solenis Switzerland GmbH site 2 Wimsey Way, Somercotes DE55 4PA Alfreton United Kingdom of Great Britain and Northern Ireland (the) Solenis Switzerland GmbH site 3 Högastensgatan 18 252 32 Helsingborg Sweden

Solenis Switzerland GmbH site 4 AD International B.V. Markweg Zuid 27 4793 ZJ Fijnaart Netherlands (the) Name of manufacturerDiversey UK Production LtdAddress of manufacturerCotes Park Industrial Estate, Somercotes DE55 4PA Alfreton United Kingdom of Great Britain and Northern Ireland (the)Location of manufacturing sites Diversey UK Production Ltd Cotes Park Industrial Estate, Somercotes, DE55 4PA Alfreton United Kingdom of Great Britain and Northern Ireland (the) Name of manufacturerDiversey Italy Production SrlAddress of manufacturerStrada Statale 235 26010 Bagnolo Cremasco (CR) ItalyLocation of manufacturing sites Diversey Italy Production Srl Strada Statale 235 26010 Bagnolo Cremasco (CR) Italy Name of manufacturerDiversey España Production S.L.UAddress of manufacturerAvenida Conde Duque 5, 7 y 9, Poligono Industrial La Postura 28343 Valdemoro (Madrid) SpainLocation of manufacturing sites Diversey España Production S.L.U Avenida Conde Duque 5, 7 y 9, Poligono Industrial La Postura 28343 Valdemoro (Madrid) Spain Name of manufacturerDiversey Netherlands Production BVAddress of manufacturerRembrandtlaan 414 7545ZW Enschede Netherlands (the)Location of manufacturing sites Diversey Netherlands Production BV Rembrandtlaan 414 7545ZW Enschede Netherlands (the) Name of manufacturerDiversey Germany Production oHGAddress of manufacturerMorschheimer Strasse 12 67292 Kirchheimbolanden GermanyLocation of manufacturing sites Diversey Germany Production oHG Morschheimer Strasse 12 67292 Kirchheimbolanden Germany 1.5. Manufacturer(s) of the active substance(s) Active substanceC(M)IT/MIT (3:1)Name of manufacturerSpecialty Electronic Materials Switzerland GmbHAddress of manufacturerBachtobelstrasse 3 8810 Horgen SwitzerlandLocation of manufacturing sites Specialty Electronic Materials Switzerland GmbH site 1 Jiangsu FOPIA Chemicals Co., Ltd, Touzeng Village 224555 Binhuai Town, Binhai County, Yancheng City, Jiangsu, China Specialty Electronic Materials Switzerland GmbH site 2 Rohm and Haas (UK) Ltd. Tyneside Works, Ellison Street, NE32 3DJ Jarrow United Kingdom of Great Britain and Northern Ireland (the) Active substanceC(M)IT/MIT (3:1)Name of manufacturerThor GmbHAddress of manufacturerLandwehrstraße 1 67346 Speyer GermanyLocation of manufacturing sites Thor GmbH site 1 Landwehrstraße 1 67346 Speyer Germany Active substanceC(M)IT/MIT (3:1)Name of manufacturerThor Quimicos de México, SA de CVAddress of manufacturerKm 182 Autopista México – Querétaro, Pedro Escobedo 76700 Querétaro MexicoLocation of manufacturing sites Thor Quimicos de México, SA de CV site 1 Km 182 Autopista México – Querétaro, Pedro Escobedo 76700 Querétaro Mexico Active substanceC(M)IT/MIT (3:1)Name of manufacturerTroy Chemical Company BVAddress of manufacturerPoortweg 4C 2612 Delft Netherlands (the)Location of manufacturing sites Troy Chemical Company BV site 1 Weifang Heaven-sent New Materials Technology Co. Ltd, Binhai Road, Changyi Coastal Economic Development Zone 261312 Weifang China Troy Chemical Company BV site 2

Dalian Xingyuan Chemistry Co., Ltd, Room 1205/1206, Pearl River International Building, No.99, Xinkai Road, Xigang District, Songmudao Chemical Industry Zone, Puwan New District 116308 Dalian China Troy Chemical Company BV site 3 Dalian Bio-Chem Company Limited, Songmudao Plant: Songmudao Chemical Industry, Zone, Puwan New District 116308 Dalian China Active substanceC(M)IT/MIT (3:1)Name of manufacturerJiangsu FOPIA Chemicals Co., LtdAddress of manufacturerTouzeng Village, Binhuai Town, Binhai County 224555 Yancheng City ChinaLocation of manufacturing sites Jiangsu FOPIA Chemicals Co., Ltd site 1 Touzeng Village, Binhuai Town, Binhai County 224555 Yancheng City China 2. PRODUCT FAMILY COMPOSITION AND FORMULATION 2.1. Qualitative and quantitative information on the composition of the family Common nameIUPAC nameFunctionCAS numberEC numberContent (%)C(M)IT/MIT (3:1)Reaction mass of 5-chloro-2-methyl-2h-isothiazol-3-one and 2-methyl-2h-isothiazol-3-one (3:1)active substance55965-84-92,2 - 20,9 % (w/w) 2.2. Type(s) of formulation Formulation type(s)AL Any other liquid PART II. SECOND INFORMATION LEVEL - META SPC(S)

1. META SPC 1 ADMINISTRATIVE INFORMATION 1.1. Meta SPC 1 identifier IdentifierMeta SPC: Meta SPC 3 1.2. Suffix to the authorisation number Number1-1 1.3. Product type(s) Product type(s) PT06: Preservatives for products during storage PT11: Preservatives for liquid-cooling and processing systems PT12: Slimicides
2. META SPC 1 COMPOSITION 2.1. Qualitative and quantitative information on the composition of the meta SPC 1 Common nameIUPAC nameFunctionCAS numberEC numberContent (%)C(M)IT/MIT (3:1)Reaction mass of 5-chloro-2-methyl-2h-isothiazol-3-one and 2-methyl-2h-isothiazol-3-one (3:1)active substance55965-84-92,2 - 6,5 % (w/w) 2.2. Type(s) of formulation of the meta SPC 1 Formulation type(s)AL Any other liquid
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1 Hazard statements H332: Harmful if inhaled. H314: Causes severe skin burns and eye damage. H317: May cause an allergic skin reaction. H410: Very toxic to aquatic life with long lasting effects. H290: May be corrosive to metals. H302: Harmful if swallowed. EUH071: Corrosive to the respiratory tract. Precautionary statements P260: Do not breathe fume. P264: Wash skin thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P272: Contaminated work clothing should not be allowed out of the workplace. P273: Avoid release to the environment. P280: Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P362+P364: Take off contaminated clothing and wash it before reuse. P333+P313: If skin irritation or rash occurs: Get medical advice. P301+P330+P331: IF SWALLOWED: rinse mouth. Do NOT induce vomiting. P303+P361+P353: IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water [or shower]. P304+P340: IF INHALED: Remove person to fresh air and keep comfortable for breathing. P310: Immediately call a POISON CENTER/ doctor.

P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P391: Collect spillage. P405: Store locked up. P234: Keep only in original packaging. P301+P312: IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P406: Store in a a corrosion-resistant container with a resistant inner liner. P390: Absorb spillage to prevent material damage. 4. AUTHORISED USE(S) OF THE META SPC 4.1. Use description Table 1 Preservation of polymer lattices Product typePT06: Preservatives for products during storageWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Field(s) of use Indoor use Preservation of polymer latexes The biocidal product is recommended for the control of bacteria, yeast and fungi in the manufacture, storage, and transport of latexes, synthetic polymers including Hydrolysed Poly Acryl Amide (HPAM) and biopolymers (e.g. xanthan, dextran..) natural latexes. Application method(s) Method: closed system Detailed description: Manual and automated application. The biocidal product should be dispensed to the end use fluid at a point to ensure adequate mixing using preferably automated metering pump or by manual addition. Application rate(s) and frequency Application rate: Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products; Professional uses: 14,9 - 50 mg /kg of C(M)IT/MIT (3:1) in final product. - Number and timing of application: The biocidal product is added at single dose at the time of manufacture, storage or shipment. To ensure uniform distribution, slowly disperse using automated metering or manual addition, into product with agitation. Mix thoroughly until evenly dispersed throughout the product. Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products. Professional uses 14,9 - 50 mg /kg of C(M)IT/MIT (3:1) in final product. For the biocidal product as supplied: for industrial use only. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.1.1. Use-specific instructions The preservative can be added at any stage of the production of the product. Earliest possible addition is recommended for optimal protection. Consult the manufacturer to determine the optimal dosage for the various products to be preserved. It is recommended that the optimum biocide concentration and compatibility with individual formulations is determined by means of laboratory tests. The duration and storage conditions of the preserved matrices may impact the efficacy of the product, microbiological tests should be conducted to determine the appropriate application rate without exceeding the maximum authorised application rate.

The biocidal product shall be used for treatment of products (articles/mixtures) distributed only to professional users. 4.1.2. Use-specific risk mitigation measures During handling phases of products from Meta SPC 1, 2, 3 and 4 (mixing and loading), exposure to the product (corrosive and skin sensitizer products) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. The maximal products concentration used for the preservation of polymer lattices being above the threshold value of 15 ppm, exposure has to be limited by use of PPE, protecting skin and mucous membranes potentially exposed, and application of technical and organisational RMM: Minimisation of manual phases; Use of a dosing device; Regular cleaning of equipment and work area; Good standard of general ventilation; Training and management of staff on good practice. 4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.2. Use description Table 2 Preservation of mineral slurries Product typePT06: Preservatives for products during storageWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Field(s) of use Indoor use Preservation of mineral slurries The biocidal product is recommended to control the growth of bacteria in aqueous-based inorganic/mineral slurries and inorganic pigments which are formulated into paints, coatings and paper. Application method(s) Method: closed system Detailed description: Manual and automated application. The biocidal product should be dispensed as a tankside additive into the circulating use-dilution of the fluid, using a metering pump or by manual pouring, at a point to assure adequate mixing throughout the system. Application rate(s) and frequency Application rate: Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products; Professional uses: 10- 30 mg/kg of C(M)IT/MIT (3:1) in final product. -

Number and timing of application: The biocidal product is added at single dose at the time of manufacture, storage or shipment. Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products. Professional uses: 10- 30 mg/kg of C(M)IT/MIT (3:1) in final product. For the biocidal product as supplied: for industrial use only. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.2.1. Use-specific instructions The preservative can be added at any stage of the production of the product. Earliest possible addition is recommended for optimal protection. Consult the manufacturer to determine the optimal dosage for the various products to be preserved. It is recommended that the optimum biocide concentration and compatibility with individual formulations is determined by means of laboratory tests. The duration and storage conditions of the preserved matrices may impact the efficacy of the product, microbiological tests should be conducted to determine the appropriate application rate without exceeding the maximum authorised application rate. The biocidal product shall be used for treatment of products (articles/mixtures) distributed only to professional users. 4.2.2. Use-specific risk mitigation measures During handling phases of products from Meta SPC 1, 2, 3 and 4 (mixing and loading), exposure to the product (corrosive and skin sensitizer products) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. The maximal products concentration used for the preservation of mineral slurries being above the threshold value of 15 ppm, exposure has to be limited by use of PPE, protecting skin and mucous membranes potentially exposed, and application of technical and organisational RMM: Minimisation of manual phases; Use of a dosing device; Regular cleaning of equipment and work area; Good standard of general ventilation; Training and management of staff on good practice. 4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

See general directions for use. 4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.3. Use description Table 3 Preservation of functional fluids (hydraulic fluids, antifreeze, corrosion inhibitors, etc. - excluding fuel additives) Product typePT06: Preservatives for products during storageWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Field(s) of use Indoor use Preservation of functional fluids (hydraulic fluids, antifreeze, corrosion inhibitors, etc. - excluding fuel additives) The biocidal product is recommended to control the growth of bacteria in functional fluids such as brake and hydraulic fluids, antifreeze additives, corrosion inhibitors, spinning fluids. The biocidal product inhibits the growth microorganisms, which would otherwise lead to odours formation, viscosity alteration, discolouration of product and premature product failure. Application method(s) Method: closed system Detailed description: Manual and automated dosing. The biocidal product should be dispensed to the end use fluid at a point to ensure adequate mixing using preferably automated metering pump or by manual addition. Application rate(s) and frequency Application rate: Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products. Professional uses: Add at a typical use rate between 6 to 30 mg C(M)IT/MIT (3:1) per kg final product to be treated. - Number and timing of application: The biocidal product is added at single dose at time of manufacturing, storage or shipment. Industrial uses: 1,5 - 14,5 % C(M)IT/MIT in the biocidal products. Professional uses: Add at a typical use rate between 6 to 30 mg C(M)IT/MIT (3:1) per kg final product to be treated For the biocidal product as supplied: for industrial use only. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.3.1. Use-specific instructions The preservative can be added at any stage of the production of the product. Earliest possible addition is recommended for optimal protection. Consult the manufacturer to determine the optimal dosage for the various products to be preserved. It is recommended that the optimum biocide concentration and compatibility with individual formulations is determined by means of laboratory tests. The duration and storage conditions of the preserved matrices may impact the efficacy of the product, microbiological tests should be conducted to determine the appropriate application rate without exceeding the maximum authorised application rate.

The biocidal product shall be used for treatment of products (articles/mixtures) distributed only to professional users. 4.3.2. Use-specific risk mitigation measures During handling phases of products from Meta SPC 1, 2, 3 and 4 (mixing and loading), exposure to the product (corrosive and skin sensitizer products) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. The maximal products concentration used for the preservation of functional fluids (hydraulic fluids, antifreeze, corrosion inhibitors, etc…) being above the threshold value of 15 ppm, exposure has to be limited by use of PPE, protecting skin and mucous membranes potentially exposed, and application of technical and organisational RMM: Minimisation of manual phases; Use of a dosing device; Regular cleaning of equipment and work area; Good standard of general ventilation; Training and management of staff on good practice. 4.3.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.3.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.3.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.4. Use description Table 4 Preservation of liquids used in closed recirculating cooling systems Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria (including Legionella pneumophila) Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Field(s) of use Indoor use Outdoor use Preservation of liquids used in closed recirculating cooling systems (Closed re-circulating cooling water systems comprise compressor cooling, air conditioning chilled water, boilers, engine jacket cooling, power supply cooling, and other industrial processes). The biocidal product is used to control the growth of aerobes and anaerobes bacteria, yeast, fungi, and biofilm in the circulating water of closed systems

Application method(s) Method: closed system Detailed description: Manual and automated dosing. Application rate(s) and frequency Application rate: Curative efficacy:- against bacteria (including L. pneumophila) at 5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 24 hours - against biofilm: 14,9 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 24 hours.- against fungi and yeasts at 1 – 3 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 48 hours. Preventive efficacy:- against bacteria (including L. pneumophila) at 3 – 14,9 g C(M)IT/MIT (3:1) / m3 of water. - against biofilm (including L. pneumophila): 3 g C(M)IT/MIT (3:1) / m3 of water. - Number and timing of application: Curative efficacy: against bacteria (including L. pneumophila) at 5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 24 hours against biofilm: 14,9 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 24 hours against fungi and yeasts at 1 – 3 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 48 hours Preventive efficacy: against bacteria (including L. pneumophila) at 3 – 14,9 g C(M)IT/MIT (3:1) / m3 of water. against biofilm (including L. pneumophila): 3 g C(M)IT/MIT (3:1) / m3 of water. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.4.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.4.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.4.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

See general directions for use. 4.4.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.4.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.5. Use description Table 5 Preservation of liquids used in small open recirculating cooling systems Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria (including Legionella pneumophila) Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Scientific name: no data Common name: Algae (green algae and cyanobacteria) Development stage: no data Field(s) of use Indoor use Outdoor use Preservation of liquids used in small open recirculating cooling systems (blowdown and recirculating flow rates, as well as total volume of water limited to 2 m3/h, and 100 m3/h and 300 m3 respectively) Process and cooling water: Used to control the growth of bacteria, algae, fungi and biofilm Application method(s) Method: open system Detailed description: Manual and automated dosing. Application rate(s) and frequency Application rate: Curative treatment Against bacteria (including L. pneumophila) at 5 – 14,9 g C(M)IT/MIT (3:1) / m3 of water , - against biofilm (including L. pneumophila) at 1,5 to 14,9 g C(M)IT/MIT (3:1) / m3 of water, - against fungi (including yeast) at 1 – 14,9 g C(M)IT/MIT (3:1) / m3 of water. Preventive treatment: - Against bacteria, green algae and cyanobacteria at 3 g C(M)IT/MIT (3:1) / m3 of water, - against biofilm (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water. - Number and timing of application: Curative treatment: Against bacteria (including L. pneumophila) at 5 – 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 24 hours against biofilm (including L. pneumophila) at 1,5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 48 hours. against fungi and yeast at 1 – 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 48 hours. Preventive treatment: against bacteria, green algae and cyanobacteria at 3 g C(M)IT/MIT (3:1) / m3 of water. against biofilm (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.5.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product.

4.5.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. Cooling fluid must not enter surface water directly. Use product only in premises that are connected to a STP. The product can only be used when the cooling towers are equipped with drift eliminators that reduce the drift at least by 99%. 4.5.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.5.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.5.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.6. Use description Table 6 Preservation of liquids used in pasteurizers, conveyor belts and air washers Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria (including Legionella pneumophila) Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Scientific name: no data Common name: Algae (green algae and cyanobacteria) Development stage: no data Field(s) of use Indoor use Outdoor use Preservation of liquids used in non-food pasteurizers and conveyor belts, air washers. Application method(s) Method: - Detailed description: The biocidal product is dosed automatically in the heat transfer fluid, in a place of good mixing (e.g. collecting sump below the conveyor belt). The feeding pipe is used to dose the biocidal product below the water level in order to limit its evaporation. Application rate(s) and frequency Application rate: Curative treatment: -against bacteria (including L. pneumophila): 5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water - against biofilm (including L. pneumophila) at 1,5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water - against fungi and yeast at 1 – 14,9 g C(M)IT/MIT (3:1) / m3 of water. Preventive treatment: Against bacteria, green algae and cyanobacteria at 3 g C(M)IT/MIT (3:1) / m3 of water, against biofilm (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water. -

Number and timing of application: Curative treatment: against bacteria (including L. pneumophila): 5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water. Contact time: 24 hours against biofilm (including L. pneumophila) at 1,5 - 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 48 hours. against fungi and yeast at 1 – 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 48 hours. Preventive treatment: Against bacteria, green algae and cyanobacteria at 3 g C(M)IT/MIT (3:1) / m3 of water. against biofilm (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.6.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. Air washers: For use only in industrial air-washer systems that maintain effective mist eliminating components. 4.6.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.6.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.6.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.6.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.7. Use description Table 7 Preservation of recirculating fluids used in textile and fiber processing, leather processing, photo-processing and fountain solution systems

Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Field(s) of use Indoor use Preservation of recirculating fluids used in textile, fiber processing, leather processing, photo-processing and fountain solution systems C(M)IT/MIT (3:1) biocidal products are used for the preservation of textile and spinning fluids, photo processing solutions, leather process (e.g. washing and soaking treatment stages) and printing fountain solutions to control the integrity of recirculating fluid by reducing microbial contamination in the bulk solution. Application method(s) Method: - Detailed description: Manual and automated dosing. The preservation of all end-products is performed in most cases highly automated by industrial users. The biocidal product is added to the central sump, basin or recirculating lines in an area with adequate mixing. Application rate(s) and frequency Application rate: Curative treatment: Against bacteria at 16-30 mg C(M)IT/MIT (3:1) per L of fluid - Number and timing of application: Curative treatment: Against bacteria at 16-30 mg C(M)IT/MIT (3:1) per L of fluid Contact time 5 days Category(ies) of usersIndustrial Pack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.7.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.7.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate.

Liquids used in textile and fiber processing fluids must not enter surface water directly. Use product only in premises that are connected to a STP. Recirculating liquids in photoprocessing systems and fountain solution systems must not enter surface water directly. Use product only in premises that are connected to a STP. 4.7.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.7.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.7.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.8. Use description Table 8 Preservation of re-circulating liquids used in paint spray booths and electrodeposition coating systems Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Field(s) of use Indoor use Preservation of re-circulating liquids used in paint spray booths and electrodeposition coating systems. The biocidal product is used for preservation of fluids in pre- treatment processes (Cleaning treatment for grease removal and soil, degreasing Phosphating process, Rinse off tanks) paint spray booths and electrodeposition coating systems (e.g. cataphoretic baths) applied in Car Refinishing and Original equipment Car Manufacturing to control the integrity of recirculating fluid by reducing microbial contamination from bacteria and fungi in the bulk solution. Application method(s) Method: - Detailed description:

Application rate(s) and frequency Application rate: Preventive treatment: 7,5 to 30 mg C(M)IT/MIT (3:1) per Kg final product. - Number and timing of application: Preventive treatment: 7,5 to 30 mg C(M)IT/MIT (3:1) per Kg final product. The biocidal product is added at the time of manufacture, storage or shipment. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.8.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.8.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step.

During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.8.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.8.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.8.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.9. Use description Table 9 Preservation of liquids used in closed recirculating heating systems and associated pipework Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use- Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria (anaerobes and aerobes (including Legionella pneumophila) Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Field(s) of use Indoor use Outdoor use Preservation of liquids used in closed recirculating heating systems and associated pipework. Pre-commission biocide flushing of new or existing pipework systems (heating and chilling pipework) includes used or new structural pipework built on industrial building projects. Closed recirculating heating systems: pre-commission biocidal product flushing of new or existing pipework systems (heating and chilling pipework) includes used or new structural pipework built on industrial building projects. The biocidal product is used to control the growth of aerobic and anaerobic bacteria, fungi and biofilm in the circulating water of closed systems. Closed systems are less susceptible to corrosion, scaling and biological fouling than open systems. However microbial problems can occur, if the system is left filled and untreated. This is due to the presence of nitrite and glycols used as nutrients by microbes. Application method(s) Method: closed system Detailed description:

Manual and automated dosing. The biocidal product is dosed automatically in the heat transfer fluid, in a place of good mixing. The feeding pipe must dose the biocidal product below the water level in order to limit the evaporation of the biocidal product. Application rate(s) and frequency Application rate: Curative treatment - against bacteria at 5 g C(M)IT/MIT (3:1) / m3 of water (including L. pneumophila) - against biofilm at 14,9 g C(M)IT/MIT (3:1) / m3 of water - against fungi and yeast at 1 g C(M)IT/MIT / m3 of water Preventive treatment - against bacteria (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water - against biofilm at 3 g C(M)IT/MIT (3:1) / m3 of water. - Number and timing of application: Curative treatment: against bacteria at 5 g C(M)IT/MIT (3:1) / m3 of water (including L. pneumophila) Contact time: 24 hours against biofilm at 14,9 g C(M)IT/MIT (3:1) / m3 of water Contact time: 24 hours against fungi and yeast at 1 g C(M)IT/MIT / m3 of water Contact time: 48 hours Preventive treatment against bacteria (including L. pneumophila) at 3 g C(M)IT/MIT (3:1) / m3 of water and against biofilm at 3 g C(M)IT/MIT (3:1) / m3 of water. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.9.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.9.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.9.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

See general directions for use. 4.9.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.9.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.10. Use description Table 10 Preservation of polymers used in oilfield processes (e.g. enhanced oil recovery, drilling muds, etc.) Product typePT11: Preservatives for liquid-cooling and processing systemsWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Field(s) of use Outdoor use Preservation of polymers used in oilfield processes (e.g. enhanced oil recovery, drilling muds, etc.) Application method(s) Method: - Detailed description:

Application rate(s) and frequency Application rate: Preventive treatment of polymers used in the injection water: Xanthan polymer: 30 -50 g C(M)IT/MIT/m3 solution. HPAM polymer: 30 - 50 g C(M)IT/MIT/m3 solution. Preventive treatment of polymers used in the drilling muds: Xanthan polymer: 30 g C(M)IT/MIT/m3 solution. HPAM polymer: 30 g C(M)IT/MIT/m3 solution. - Number and timing of application: Preventive treatment of polymers used in the injection water: Xanthan polymer: 30 -50 g C(M)IT/MIT/m3 solution. HPAM polymer: 30 - 50 g C(M)IT/MIT/m3 solution. Preventive treatment of polymers used in the drilling muds: Xanthan polymer: 30 g C(M)IT/MIT/m3 solution. HPAM polymer: 30 g C(M)IT/MIT/m3 solution. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.10.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.10.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information);

protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.10.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.10.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.10.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.11. Use description Table 11 Slimicide treatment in the de-inking process of the pulp and paper Product typePT12: SlimicidesWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Field(s) of use Indoor use Slimicide treatment in the de-inking process of the pulp and paper. Recycling paper /deinking paper mills. Deinking process is a manufacturing paper process of removing printing inks from waste paper-fibers to produce deinked pulp. Application method(s) Method: closed system Detailed description: Manual and automated dosing. The biocidal product is automatically dosed by pump and fixed pipes into the circuit, usually in the pulper below the water level. Application rate(s) and frequency Application rate: Curative treatment: 10 to 14,9 g C(M)IT/MIT (3:1) / m3 of water to be treated. Preventive treatment: 5 g C(M)IT/MIT (3:1) / m3 of water to be treated. - Number and timing of application: Curative treatment: 10 to 14,9 g C(M)IT/MIT (3:1) / m3 of water to be treated Contact time: 24 hours Preventive treatment: 5 g C(M)IT/MIT (3:1) / m3 of water to be treated. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.11.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.11.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM:

Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. 4.11.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.11.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.11.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.12. Use description Table 12 Slimicide treatment in the wet-end stage of paper manufacturing process Product typePT12: SlimicidesWhere relevant, an exact description of the authorised use- Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: fungi Development stage: no data Field(s) of use Indoor use Slimicide treatment in the wet-end stage of the paper manufacturing process (paper mills, wet-end stage (water circuits), and paper mills process system). Application method(s) Method: closed system Detailed description: Manual and automated dosing. Application rate(s) and frequency Application rate: Curative treatment: 10 to 14,9 g C(M)IT/MIT (3:1) / m3 of water to be treated. Preventive treatment: 5 g C(M)IT/MIT (3:1) / m3 of water to be treated. - Number and timing of application: Curative treatment: 10 to 14,9 g C(M)IT/MIT (3:1) / m3 of water to be treated Contact time: 24 hours Preventive treatment: 5 g C(M)IT/MIT (3:1) / m3 of water to be treated. Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.12.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product.

4.12.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. The use of C(M)IT/MIT (3:1) containing products for the slimicide treatment in the wet-end stage of the paper manufacturing process is restricted to a) curative treatments in plants connected to a slimicide-free water from a pulp mill and only for the treatment of the short circulation of the paper mill; and b) preventive treatments, and, for both cases, only if the factory’s waste water is purified in an on-site (full) industrial sewage treatment plant with a minimal capacity of 5000 m3 per day as described in the Industrial Emission Directive 2010/75/EU (Best Available Techniques for the production of pulp, paper and board) and if a dilution of at least 200 times in surface water is achieved after the industrial sewage treatment plant. 4.12.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.12.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.12.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 4.13. Use description Table 13 Preventive treatment (biofouling control) online and after cleaning in place for industrial RO/NF membranes Product typePT12: SlimicidesWhere relevant, an exact description of the authorised use-Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Field(s) of use Indoor use Preventive treatment (biofouling control) online and after cleaning in place for industrial RO/NF membranes Application method(s) Method: closed system Detailed description: Manual and automated dosing.Biocidal product application on a routine basis will prevent biofilm growth on Reverse Osmosis or Nano Filtration membrane surfaces, feed spacer, filter media and pipework. The biocidal product should be dispensed to the feed water at a point to assure adequate mixing throughout the system.

Application rate(s) and frequency Application rate: Preventive treatment: 5 g C(M)IT/MIT (3:1) per m3 of fluid - Number and timing of application: Preventive treatment: 5 g C(M)IT/MIT (3:1) per m3 of fluid Category(ies) of usersIndustrialPack sizes and packaging material For industrial and professional users: HDPE flask: 5 L (nominal) HDPE Pail / Jerrycan: 10 L, 20 L, 25 L, 30 L (nominal) Box with HDPE liner: 20 L HDPE Drum: 110 L, 120 L, 200 L, 260 L HDPE IBC: 650 L, 800 L, 1000 L, 1250 L All products should be transport and stored in a vented room. 4.13.1. Use-specific instructions Microbiological tests to prove adequacy of preservation have to be undertaken by the user of C(M)IT/MIT products in order to determine the effective dose of the preservative for the specific matrix/location/system. If needed, consult the manufacturer of the preservative product. 4.13.2. Use-specific risk mitigation measures Rinse the system (especially the dispensing pumps) with water prior to perform the cleaning step. During handling phases (mixing and loading) and cleaning of the dispensing pumps, exposure to the product (corrosive and skin sensitizer product) has to be limited by use of PPE and application of technical and organisational RMM: Minimisation of manual phases (process automation); Use of a dosing device; Regular cleaning of equipment and work area; Avoidance of contact with contaminated tools and objects; Good standard of general ventilation; Training and management of staff on good practice. PPE is as follows: protective chemical resistant gloves (glove material to be specified by the authorisation holder within the product information); protective coverall (at least type 3 or 4, EN 14605) which is impermeable for the biocidal product shall be worn (coverall material to be specified by the authorisation holder within the product information); Eye protection; Substance/task appropriate respirator if ventilation is inadequate. Use product only in premises that are connected to a STP. 4.13.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use. 4.13.4. Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use. 4.13.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 1 5.1. Instructions for use The duration of the effect is dependent on the performance requirements of the customer for their preserved material and on the specific ingredients composition and pH of the preserved product. Always read the label or leaflet before use and follow all the instructions provided. Respect the conditions of use of the product (concentration, contact time, temperature, pH, etc.) PRECAUTIONARY MEASURES DURING STORAGE AND TRANSPORT:

Keep in a well-ventilated place. The product as supplied may evolve gas (largely carbon dioxide) slowly. To prevent the buildup of pressure the product is packaged in specially vented containers, where necessary. Keep this product in the original container when not in use. Container must be stored and transported in an upright position to prevent spilling the contents through the vent, where fitted. 5.2. Risk mitigation measures

5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment Skin contact: Remove contaminated clothing and shoes. Wash contaminated skin with water. Contact poison treatment specialist if symptoms occur. Eye contact: Immediately flush with plenty of water, occasionally lifting the upper and lower eyelids. Check for and remove any contact lenses if easy to do. Continue to rinse with tepid water for at least 30 minutes. Call 112/ambulance for medical assistance. Ingestion: Wash out mouth with water. Contact poison treatment specialist. Seek medical advice immediately if symptoms occur and/or large quantities have been ingested. Do not give fluids or induce vomiting. Inhalation (of spray mist): Remove victim to fresh air and keep at rest in a position comfortable for breathing. Seek medical advice immediately if symptoms occur and/or large quantities have been inhaled. In case of impaired consciousness place in recovery position and seek medical advice immediately. Keep the container or label available. 5.4. Instructions for safe disposal of the product and its packaging Do not discharge unused product on the ground, into water courses, into pipes (e.g. sink, toilets) nor down the drains. Dispose of unused product, its packaging and all other waste, in accordance with local regulations. 5.5. Conditions of storage and shelf-life of the product under normal conditions of storage Conditions for safe storage, including any incompatibilities: Keep in a dry, cool and well-ventilated place, in the original container. Shelf-life: 12 months Protect from sunlight. Recommendation: If a metal packaging is used, a varnish layer should be applied. 6. OTHER INFORMATION

1. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1 7.1. Trade name(s), authorisation number and specific composition of each individual product Trade name(s)Spectrum™ RX6804 MICROBIOCIDEMarket area: EUAuthorisation numberEU-0025678-0001 1-1Common nameIUPAC nameFunctionCAS numberEC numberContent (%)C(M)IT/MIT (3:1)Reaction mass of 5-chloro-2-methyl-2h-isothiazol-3-one and 2-methyl-2h-isothiazol-3-one (3:1)active substance55965-84-95,9 % (w/w) 7.2. Trade name(s), authorisation number and specific composition of each individual product Trade name(s)Spectrum™ PR3126 PRESERVATIVEMarket area: EUSpectrum™ RX8560 MICROBIOCIDEMarket area: EUSpectrum™ RX7827 MICROBIOCIDEMarket area: EUAuthorisation numberEU-0025678-0002 1-1Common nameIUPAC nameFunctionCAS numberEC numberContent (%)C(M)IT/MIT (3:1)Reaction mass of 5-chloro-2-methyl-2h-isothiazol-3-one and 2-methyl-2h-isothiazol-3-one (3:1)active substance55965-84-93,2 % (w/w)

7.3. Trade name(s), authorisation number and specific composition of each individual product Trade name(s)Biosperse™ 250 MICROBIOCIDEMarket area: EUBiosperse™ 251 MICROBIOCIDEMarket area: EUBiosperse™ 850 MICROBIOCIDEMarket area: EUBiosperse™ 851 MICROBIOCIDEMarket area: EUSpectrum™ RX6810 MICROBIOCIDEMarket area: EUSpectrum™ RX6820 MICROBIOCIDEMarket area: EUAuthorisation numberEU-0025678-0003 1-1 Common nameIUPAC nameFunctionCAS numberEC numberContent (%)C(M)IT/MIT (3:1)Reaction mass of 5-chloro-2-methyl-2h-isothiazol-3-one and 2-methyl-2h-isothiazol-3-one (3:1)active substance55965-84-92,3 % (w/w)